Literature DB >> 23408837

Tissue-derived hedgehog proteins modulate Th differentiation and disease.

Anna L Furmanski1, Jose Ignacio Saldana, Masahiro Ono, Hemant Sahni, Nikolaos Paschalidis, Fulvio D'Acquisto, Tessa Crompton.   

Abstract

Genome-wide association studies of complex immune-mediated diseases have indicated that many genetic factors, each with individual low risk, contribute to overall disease. It is therefore timely and important to characterize how immune responses may be subtly modified by tissue context. In this article, we explore the role of tissue-derived molecules in influencing the function of T cells, which, owing to their migratory nature, come into contact with many different microenvironments through their lifespan. Hedgehog (Hh) proteins act as secreted morphogens, providing concentration-dependent positional and temporal cell-fate specification in solid tissues. Hh signaling is required for embryogenesis and is important in postnatal tissue renewal and in malignancy. However, the function of Hh in dynamic, fluid systems, such as in mammalian immunity, is largely unknown. In this article, we show that Hh-dependent transcription in T cells promoted Th2 transcriptional programs and differentiation, exacerbating allergic disease. Of interest, expression of Sonic Hh increased in lung epithelial cells following the induction of allergic disease, and lung T cells upregulated Hh target gene expression, indicating that T cells respond to locally secreted Hh ligands in vivo. We show that Il4, the key Th2 cytokine, is a novel transcriptional target of Hh signals in T cells, providing one mechanism for the role of Hh in Th differentiation. We propose that Hh, secreted from inflamed, remodeling, or malignant tissue, can modulate local T cell function. Our data present an unexpected and novel role for tissue-derived morphogens in the regulation of fluid immune responses, with implications for allergy and tumor responses, suggesting new uses for anti-Hh therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408837      PMCID: PMC3672981          DOI: 10.4049/jimmunol.1202541

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism.

Authors:  W Ouyang; S H Ranganath; K Weindel; D Bhattacharya; T L Murphy; W C Sha; K M Murphy
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

2.  Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation.

Authors:  S Agarwal; A Rao
Journal:  Immunity       Date:  1998-12       Impact factor: 31.745

3.  The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells.

Authors:  W Zheng; R A Flavell
Journal:  Cell       Date:  1997-05-16       Impact factor: 41.582

Review 4.  Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms.

Authors:  Chi Young Ok; Rajesh Ramachandra Singh; Francisco Vega
Journal:  Am J Pathol       Date:  2011-11-01       Impact factor: 4.307

5.  Sonic hedgehog signaling modulates activation of and cytokine production by human peripheral CD4+ T cells.

Authors:  Gareth A Stewart; Jacqueline A Lowrey; Sonia J Wakelin; Paul M Fitch; Susannah Lindey; Margaret J Dallman; Jonathan R Lamb; Sarah E M Howie
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

Review 6.  What determines Th2 differentiation, in vitro and in vivo?

Authors:  William E Paul
Journal:  Immunol Cell Biol       Date:  2010-02-16       Impact factor: 5.126

7.  EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion.

Authors:  Alexandra Ziegler; Regina Heidenreich; Heidi Braumüller; Hartwig Wolburg; Susanne Weidemann; Ralph Mocikat; Martin Röcken
Journal:  Blood       Date:  2009-02-02       Impact factor: 22.113

8.  Reduced thymocyte development in sonic hedgehog knockout embryos.

Authors:  Divya K Shah; Ariadne L Hager-Theodorides; Susan V Outram; Susan E Ross; Alberto Varas; Tessa Crompton
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

9.  Role of Hedgehog signalling at the transition from double-positive to single-positive thymocyte.

Authors:  Anna L Furmanski; Jose Ignacio Saldana; Nicola J Rowbotham; Susan E Ross; Tessa Crompton
Journal:  Eur J Immunol       Date:  2011-12-16       Impact factor: 5.532

10.  Activation of the Hedgehog signaling pathway in T-lineage cells inhibits TCR repertoire selection in the thymus and peripheral T-cell activation.

Authors:  Nicola J Rowbotham; Ariadne L Hager-Theodorides; Marek Cebecauer; Divya K Shah; Ekati Drakopoulou; Julian Dyson; Susan V Outram; Tessa Crompton
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

View more
  45 in total

Review 1.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.

Authors:  Hiam Abdala-Valencia; Mackenzie E Coden; Sergio E Chiarella; Elizabeth A Jacobsen; Bruce S Bochner; James J Lee; Sergejs Berdnikovs
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

Review 2.  Sonic hedgehog signaling in the lung. From development to disease.

Authors:  Matthias C Kugler; Alexandra L Joyner; Cynthia A Loomis; John S Munger
Journal:  Am J Respir Cell Mol Biol       Date:  2015-01       Impact factor: 6.914

Review 3.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

4.  Reemergence of hedgehog mediates epithelial-mesenchymal crosstalk in pulmonary fibrosis.

Authors:  Biao Hu; Jianhua Liu; Zhe Wu; Tianju Liu; Matthew R Ullenbruch; Lin Ding; Craig A Henke; Peter B Bitterman; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2015-04       Impact factor: 6.914

Review 5.  Origins of the cytolytic synapse.

Authors:  Maike de la Roche; Yukako Asano; Gillian M Griffiths
Journal:  Nat Rev Immunol       Date:  2016-06-06       Impact factor: 53.106

Review 6.  Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases.

Authors:  Robert P Schleimer; Sergejs Berdnikovs
Journal:  J Allergy Clin Immunol       Date:  2017-06       Impact factor: 10.793

7.  S100a4-Cre-mediated deletion of Patched1 causes hypogonadotropic hypogonadism: role of pituitary hematopoietic cells in endocrine regulation.

Authors:  Yi Athena Ren; Teresa Monkkonen; Michael T Lewis; Daniel J Bernard; Helen C Christian; Carolina J Jorgez; Joshua A Moore; John D Landua; Haelee M Chin; Weiqin Chen; Swarnima Singh; Ik Sun Kim; Xiang Hf Zhang; Yan Xia; Kevin J Phillips; Harry MacKay; Robert A Waterland; M Cecilia Ljungberg; Pradip K Saha; Sean M Hartig; Tatiana Fiordelisio Coll; JoAnne S Richards
Journal:  JCI Insight       Date:  2019-07-02

8.  Novel genetic risk factors for asthma in African American children: Precision Medicine and the SAGE II Study.

Authors:  Marquitta J White; O Risse-Adams; P Goddard; M G Contreras; J Adams; D Hu; C Eng; S S Oh; A Davis; K Meade; E Brigino-Buenaventura; M A LeNoir; K Bibbins-Domingo; M Pino-Yanes; E G Burchard
Journal:  Immunogenetics       Date:  2016-05-03       Impact factor: 2.846

9.  Bardet-Biedl Syndrome ciliopathy is linked to altered hematopoiesis and dysregulated self-tolerance.

Authors:  Oksana Tsyklauri; Veronika Niederlova; Elizabeth Forsythe; Avishek Prasai; Ales Drobek; Petr Kasparek; Kathryn Sparks; Zdenek Trachtulec; Jan Prochazka; Radislav Sedlacek; Philip Beales; Martina Huranova; Ondrej Stepanek
Journal:  EMBO Rep       Date:  2021-01-11       Impact factor: 8.807

10.  The hedgehog pathway suppresses neuropathogenesis in CD4 T cell-driven inflammation.

Authors:  Nail Benallegue; Hania Kebir; Richa Kapoor; Alexis Crockett; Cen Li; Lara Cheslow; Mohamed S Abdel-Hakeem; James Gesualdi; Miles C Miller; E John Wherry; Molly E Church; M Andres Blanco; Jorge I Alvarez
Journal:  Brain       Date:  2021-07-28       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.